{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Stage+2&page=6", "query": { "intervention": "Stage 2", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 33431, "total_pages": 3344, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Stage+2&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Stage+2&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T21:52:05.537Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01683149", "title": "Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor" ], "interventions": [ { "name": "Topotecan", "type": "DRUG" }, { "name": "Sorafenib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Years to 18 Years" }, "enrollment_count": 13, "start_date": "2013-01", "completion_date": "2016-01", "has_results": false, "last_update_posted_date": "2016-03-04", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 9, "location_summary": "Los Angeles, California • Hartford, Connecticut • Wilmington, Delaware + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01683149" }, { "nct_id": "NCT00730158", "title": "A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Neoplasms" ], "interventions": [ { "name": "KD018", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Edward Chu, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2008-12", "completion_date": "2018-06", "has_results": true, "last_update_posted_date": "2019-05-22", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 2, "location_summary": "New Haven, Connecticut • Pittsburgh, Pennsylvania", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00730158" }, { "nct_id": "NCT00804258", "title": "Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ovarian Cancer" ], "interventions": [ { "name": "intraperitoneal chemotherapy", "type": "DRUG" }, { "name": "educational intervention", "type": "OTHER" }, { "name": "medical chart review", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "assessment of therapy complications", "type": "PROCEDURE" }, { "name": "end-of-life treatment/management", "type": "PROCEDURE" }, { "name": "psychosocial assessment and care", "type": "PROCEDURE" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 17, "start_date": "2007-08", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2015-11-06", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00804258" }, { "nct_id": "NCT02024555", "title": "Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoidosis; Antimycobacterial Therapy" ], "interventions": [ { "name": "Levofloxacin", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 97, "start_date": "2014-03", "completion_date": "2019-04-01", "has_results": true, "last_update_posted_date": "2020-07-09", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 6, "location_summary": "Albany, New York • Cincinnati, Ohio • Cleveland, Ohio + 3 more", "locations": [ { "city": "Albany", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024555" }, { "nct_id": "NCT01922128", "title": "Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nonexudative Age-related Macular Degeneration" ], "interventions": [ { "name": "MC-1101, Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MacuCLEAR, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 20, "start_date": "2013-09", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 1, "location_summary": "Artesia, California", "locations": [ { "city": "Artesia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01922128" }, { "nct_id": "NCT04642365", "title": "A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "RO7296682", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2021-01-04", "completion_date": "2024-01-04", "has_results": true, "last_update_posted_date": "2025-05-21", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04642365" }, { "nct_id": "NCT03682107", "title": "Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hantavirus Pulmonary Infection", "Immunisation" ], "interventions": [ { "name": "Andes virus DNA vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 48, "start_date": "2019-02-19", "completion_date": "2020-09-23", "has_results": true, "last_update_posted_date": "2022-11-22", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03682107" }, { "nct_id": "NCT06666192", "title": "The Ohio State University (OSU) SCREEN Community Program", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Carcinoma", "Cervical Carcinoma", "Colorectal Carcinoma" ], "interventions": [ { "name": "Cancer Screening", "type": "OTHER" }, { "name": "Discussion", "type": "OTHER" }, { "name": "Educational Activity", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Focus Group", "type": "BEHAVIORAL" }, { "name": "Health Care Delivery", "type": "OTHER" }, { "name": "Health Promotion", "type": "OTHER" }, { "name": "Health Promotion and Education", "type": "OTHER" }, { "name": "Health Risk Assessment", "type": "BEHAVIORAL" }, { "name": "Implementation", "type": "PROCEDURE" }, { "name": "Informational Intervention", "type": "OTHER" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Outreach", "type": "BEHAVIORAL" }, { "name": "Patient Navigation", "type": "BEHAVIORAL" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2067, "start_date": "2024-03-12", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2025-12-24", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06666192" }, { "nct_id": "NCT00000971", "title": "The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Mycobacterium Avium-intracellulare Infection", "HIV Infections" ], "interventions": [ { "name": "Clarithromycin", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" }, { "name": "Didanosine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 24, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2008-08-04", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 2, "location_summary": "Los Angeles, California • Bethesda, Maryland", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000971" }, { "nct_id": "NCT02942771", "title": "A MAD Study of TT301/MW189 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adult Volunteers" ], "interventions": [ { "name": "0.075mg/kg TT301/MW189", "type": "DRUG" }, { "name": "0.15mg/kg TT301MW189", "type": "DRUG" }, { "name": "0.25mg/kg TT301/MW189", "type": "DRUG" }, { "name": "0.30mg/kg TT301/MW189", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Linda Van Eldik", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 35, "start_date": "2017-03-20", "completion_date": "2018-06-04", "has_results": true, "last_update_posted_date": "2020-06-16", "last_synced_at": "2026-10-30T21:52:05.537Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02942771" } ] }